Darmstadt, Germany

Richard Kirchlechner

This inventor holds 5 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft MIT Beschraenkter Haftung. Active years: 1976-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 160(Granted Patents)


Location History:

  • Darmstadt, DE (1976 - 1977)
  • Hahnlein, DE (1980)
  • Rott a. Inn, DE (1986)
  • Rott, DE (1991)

Company Filing History:


Years Active: 1976-1991

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Richard Kirchlechner: Innovator in Pharmaceutical Chemistry

Introduction

Richard Kirchlechner is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 5 patents to his name, Kirchlechner's work has had a meaningful impact on the industry.

Latest Patents

Among his latest patents, Kirchlechner has developed a process for the preparation of 5-membered nitrogen-containing flavonoid phosphate salts of aminoglycoside antibiotics. These flavonoid phosphates are recognized for their utility as sparingly soluble salts, which can be beneficial for achieving a depot effect in medical applications.

Career Highlights

Throughout his career, Kirchlechner has worked with prominent organizations, including Merck Patent Gesellschaft mit beschränkter Haftung. His expertise in pharmaceutical innovations has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Kirchlechner has collaborated with esteemed colleagues such as Werner Rogalski and Helmut Wahlig. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Richard Kirchlechner's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…